PharmaTher Holdings Ltd.
PHRRF
$0.08
$0.003.33%
OTC PK
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 44.48% | -18.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.23% | 3.51% | |||
| Operating Income | -53.23% | -3.51% | |||
| Income Before Tax | -12.59% | 3.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.59% | 3.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.59% | 3.40% | |||
| EBIT | -53.23% | -3.51% | |||
| EBITDA | -53.25% | -3.56% | |||
| EPS Basic | -13.79% | 3.33% | |||
| Normalized Basic EPS | -50.00% | -5.88% | |||
| EPS Diluted | -13.79% | 3.33% | |||
| Normalized Diluted EPS | -50.00% | -5.88% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||